Category Archives: Biotech

CDI

CDI, Roche to Collaborate

Cellular Dynamics International announced Tuesday that it will supply Roche with induced pluripotent stem cell (iPSC)-derived iCell products. According to a release, Roche will have exclusive access to specific iCell products to be employed…

Exact Sciences to Expand at URP

Exact Sciences is staying on the west side. The biotech company is planning to expand its footprint at its current headquarters at University Research Park rather than expand downtown, according…

Pointcare Genomics Lands $300K Grant

Pointcare Genomics Corporation announced this week it is the recipient of a $300,000 SBIR Phase I grant. According to a release, the money from the National Cancer Institute will help develop…

Exact Sciences logo

Study Shows Cologuard’s Efficacy

A peer-reviewed study of Exact Sciences‘ Cologuard confirmed its ability to detect colorectal cancer, the organization announced today. According to a release, Cologuard detected 100 percent of colorectal cancers and 52…

InvivoSciences Earns $700K Grant

InvivoSciences announced today it is the recipient of a $700,000 SBIR grant. According to a release, the money from the National Institute of Aging will help InvivoSciences collaborate with the Torrey Pines…

HealthMyne, Moffitt Cancer Center to Collaborate

HealthMyne announced this week it will work with Moffitt Cancer Center on research and product evaluation, with the goal of implementing an imaging analytics software platform. No terms were released…

SHINE Medical Technologies logo

SHINE Names Todd Asmuth President

SHINE Medical Technologies announced recently that former Aquamost CEO Todd Asmuth has been named president and will focus on investor and customer relations. “SHINE has an amazing opportunity in front…

Cellectar Biosciences logo

Cellectar Biosciences Nabs SBIR Grant

Cellectar Biosciences announced today it is the recipient of a $2.3 million Fast-Track SBIR grant. According to a release, the money from the National Cancer Institute will help fund development of the…

Cellectar Biosciences logo

Cellectar Looks to Raise $3.3M

Cellectar Biosciences today announced it is looking to raise $3.3 million through Wednesday by pricing common stock at $2.20 per share. According to a release, the company looks to use the…

Stemina Receives $2.7M Grant

Stemina Biomarker Discovery Inc., a company focused on diagnosis and individualized treatment of neurological disorders, received a $2.7 million grant from the National Institute of Mental Health (NIMH) to support the Children’s Autism…